C1orf147

Across TCGA pan-cancer cohorts, C1orf147 RNA differs between tumor and matched normal tissue in 12 of 18 cancer types tested, making tumor–normal expression one of C1orf147’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where C1orf147 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types C1orf147 is over-expressed in tumor.

KIRC, COAD, and KIRP are the cancer types where C1orf147 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in C1orf147 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	Male	All	+0.121	<.001	11	view →
COAD	Female	All	+0.359	<.001	9	view →
KIRP	All	All	+0.117	<.001	8	view →
LUAD	Female	All	+0.389	<.001	7	view →
STAD	All	All	+0.276	<.001	6	view →
LIHC	Female	All	+0.058	<.001	6	view →
LUSC	Male	All	+0.302	<.001	4	view →
BRCA	All	II,III,IV	+0.205	<.001	4	view →
CHOL	All	All	+0.337	<.001	2	view →
BLCA	All	III,IV	+0.203	.012	2	view →
UCEC	All	All	+0.149	.030	2	view →
READ	All	All	+0.256	.046	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 12 strongest of 12 lineages.

C1orf147–KIRC

Open the KIRC breakdown →